Medical device groups float – then sink
Medtechs rushed for the markets last year, but had an uneasy time once there.
Device makers buy big
Whether sitting on a pile of cash or guarding against growing pressures, acquisitions are the answer.
Medtech developments over the Christmas period
The FDA scrambles for more rapid Covid-19 tests, and the device sector enjoys a late flurry of deals.
Smaller medtechs suffer, but not from Covid-19
Emergence from lockdown is the driving force behind many – but not all – of the small and mid-cap share price moves.
Ortho Clinical takes a haircut
Discount pricing and poor first day defies the recent trend for floating device makers.
A new setting for antigen testing
It is vital that the first authorised at-home, non-prescription Covid-19 antigen test be used in the right way.